Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.83
0.0350.60%
Last update: Dec 15, 10:07 AM
Comments
Loading...
Taysha Gene Therapies (TSHA) Stock Price, Quote, News & History
TSHANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Taysha Gene Therapies (TSHA) stock?
You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.
Who are Taysha Gene Therapies (TSHA) competitors?
Other companies in Taysha Gene Therapies’s space includes: Immunome Inc (NASDAQ:IMNM), Precigen Inc (NASDAQ:PGEN), Upstream Bio Inc (NASDAQ:UPB), Syndax Pharmaceuticals Inc (NASDAQ:SNDX) and Immatics NV (NASDAQ:IMTX).
What is the forecast, or price target, for Taysha Gene Therapies (TSHA) stock?
Taysha Gene Therapies has a consensus price target of $7.94.
What is the current price for Taysha Gene Therapies (TSHA)?
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $5.825 last updated December 15, 2025 at 10:07 AM EST.
Does Taysha Gene Therapies (TSHA) pay a dividend?
There are no upcoming dividends for Taysha Gene Therapies.
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies does not have any upcoming earnings scheduled.
Is Taysha Gene Therapies (TSHA) going to split?
There is no upcoming split for Taysha Gene Therapies.
What sector and industry does Taysha Gene Therapies (TSHA) operate in?
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
